Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

[1]  Nick C Fox,et al.  Whole‐brain atrophy as a measure of progression in premanifest and early Huntington's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[2]  Nick C. Fox,et al.  Defective emotion recognition in early HD is neuropsychologically and anatomically generic , 2008, Neuropsychologia.

[3]  K. Marder,et al.  Spectrum of gait impairments in presymptomatic and symptomatic Huntington's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[4]  Christopher Kennard,et al.  Oculomotor deficits indicate the progression of Huntington's disease. , 2008, Progress in brain research.

[5]  Stefan Klöppel,et al.  White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. , 2008, Brain : a journal of neurology.

[6]  Jane S. Paulsen,et al.  Detection of Huntington’s disease decades before diagnosis: the Predict-HD study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[7]  Daniel Ecker,et al.  Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. , 2007, Brain : a journal of neurology.

[8]  Jane S. Paulsen,et al.  fMRI detection of early neural dysfunction in preclinical Huntington's disease , 2007, Journal of the International Neuropsychological Society.

[9]  Jane S. Paulsen,et al.  Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease. , 2007, Brain : a journal of neurology.

[10]  D. Craufurd,et al.  Psychiatric disorders in preclinical Huntington’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  C. Kennard,et al.  Identification of an oculomotor biomarker of preclinical Huntington disease , 2006, Neurology.

[12]  Jane S. Paulsen,et al.  Preparing for preventive clinical trials: the Predict-HD study. , 2006, Archives of neurology.

[13]  Andrea Ciarmiello,et al.  Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  Jane S. Paulsen,et al.  Brain Structure in Preclinical Huntington’s Disease , 2006, Biological Psychiatry.

[15]  Multimodal objective assessment of motor deficits in Huntington's disease using isometric force analysis , 2005 .

[16]  B Fischl,et al.  Regional cortical thinning in preclinical Huntington disease and its relationship to cognition , 2005, Neurology.

[17]  J. Brandt,et al.  Onset and rate of striatal atrophy in preclinical Huntington disease , 2004, Neurology.

[18]  Jane S. Paulsen,et al.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length , 2004, Clinical genetics.

[19]  D. Munoz,et al.  Look away: the anti-saccade task and the voluntary control of eye movement , 2004, Nature Reviews Neuroscience.

[20]  C D Good,et al.  The distribution of structural neuropathology in pre-clinical Huntington's disease. , 2002, Brain : a journal of neurology.

[21]  Greg Harris,et al.  Structural MR image processing using the BRAINS2 toolbox. , 2002, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[22]  A. Dale,et al.  Regional and progressive thinning of the cortical ribbon in Huntington’s disease , 2002, Neurology.

[23]  J. Hodges,et al.  Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects , 2002, Acta psychiatrica Scandinavica.

[24]  D. Craufurd,et al.  Behavioral changes in Huntington Disease. , 2001, Neuropsychiatry, neuropsychology, and behavioral neurology.

[25]  Anders M. Dale,et al.  Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex , 2001, IEEE Transactions on Medical Imaging.

[26]  E. Siemers,et al.  Subtle changes among presymptomatic carriers of the Huntington's disease gene , 2000, Journal of neurology, neurosurgery, and psychiatry.

[27]  A. Gordon,et al.  Coordination of Prehensile Forces during Precision Grip in Huntington's Disease , 2000, Experimental Neurology.

[28]  René Hen,et al.  Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.

[29]  R. Shadmehr,et al.  Motor disorder in Huntington's disease begins as a dysfunction in error feedback control , 2000, Nature.

[30]  E. Siemers,et al.  Rate of functional decline in Huntington’s disease , 2000, Neurology.

[31]  J. D. de Yébenes,et al.  Clinical correlation of striatal 1H MRS changes in Huntington’s disease , 1999, Neurology.

[32]  Nick C Fox,et al.  Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. , 1997, Computer methods and programs in biomedicine.

[33]  M. MacDonald,et al.  CAG repeat number governs the development rate of pathology in Huntington's disease , 1997, Annals of neurology.

[34]  D. Brooks,et al.  Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease , 1996, Annals of neurology.

[35]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[36]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[37]  J. Penney,et al.  Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.

[38]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[39]  S. Fahn,et al.  Huntington disease , 1979, Neurology.